Journal of the American Society of Nephrology
2008 JASN IMPACT FACTOR 7.505 HOME   AUTHOR INFO   EDITORIAL BOARD   SUBSCRIBE   FEEDBACK   ALERTS   HELP 
    advanced
CURRENT ISSUE ARCHIVES JASN Express ONLINE SUBMISSION


This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow reprints & permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Shahbazi, M.
Right arrow Articles by Harden, P. N.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Shahbazi, M.
Right arrow Articles by Harden, P. N.
J Am Soc Nephrol 13:260-264, 2002
© 2002 American Society of Nephrology

BRIEF COMMUNICATIONS

Vascular Endothelial Growth Factor Gene Polymorphisms Are Associated with Acute Renal Allograft Rejection

Majid Shahbazi{ddagger}, Anthony A. Fryer{dagger}, Vera Pravica{ddagger}, Iain J. Brogan{ddagger}, Helen M. Ramsay*, Ian V. Hutchinson{ddagger} and Paul N. Harden*

Departments of *Nephrology and {dagger}Biochemistry, North Staffordshire Hospital, Stoke-on-Trent, United Kingdom; and {ddagger}School of Biological Sciences, University of Manchester, Manchester, United Kingdom.

Correspondence to Dr. Paul Harden, Department of Nephrology, North Staffordshire Hospital, Hartshill, Stoke-on-Trent, Staffordshire, UK. Phone: 0044-1782-554745; Fax: 0044-1782-620759; E-mail: pnharden{at}netscape.net

Abstract

ABSTRACT. Acute rejection is a major cause of reduced survival of renal allografts. Vascular endothelial growth factor (VEGF) is a mitogen for endothelial cells and is expressed widely by renal tissue and T cells. VEGF influences adhesion and migration of leukocytes across the endothelium. This study investigates whether genetically determined variation in VEGF expression influences the development of renal allograft rejection. VEGF promoter polymorphisms were examined by using sequence-specific primer–PCR in 173 renal transplant recipients. Acute rejection occurred in 38.7%; median time to first rejection episode was 14 d. VEGF in vitro expression was investigated in stimulated leukocytes from 30 controls. The -1154*G and -2578*C alleles were associated with higher VEGF production. VEGF -1154 GG and GA genotypes were significantly associated with acute rejection risk at 3 mo (P = 0.004, odds ration [OR] = 6.8, 95% CI = 1.8 to 25 and P = 0.035, OR = 4.1, 95% CI = 1.1 to 15, respectively). Furthermore, VEGF -2578 CC and CA genotypes were associated with increased rejection risk (P = 0.005, OR = 4.1, 95% CI = 1.5 to 11.3 and P = 0.035, OR = 2.7, 95% CI = 1.1 to 7, respectively). These polymorphisms demonstrate linkage disequilibrium (P = 0.001). These data indicate that the -1154*G and -2578*C containing genotypes, encoding higher VEGF production, are strongly associated with acute rejection and may be useful markers of rejection risk.




This article has been cited by other articles:


Home page
 Mol Hum ReprodHome page
V. C. Sandrim, A. C. T. Palei, R. C. Cavalli, F. M. Araujo, E. S. Ramos, G. Duarte, and J. E. Tanus-Santos
Vascular endothelial growth factor genotypes and haplotypes are associated with pre-eclampsia but not with gestational hypertension
Mol. Hum. Reprod., February 1, 2009; 15(2): 115 - 120.
[Abstract] [Full Text] [PDF]

Home page
 Clin. Cancer Res.Home page
S.-H. Tan, S.-C. Lee, B.-C. Goh, and J. Wong
Pharmacogenetics in Breast Cancer Therapy
Clin. Cancer Res., December 15, 2008; 14(24): 8027 - 8041.
[Abstract] [Full Text] [PDF]

Home page
 Cancer Res.Home page
A. Basu, A. G. Contreras, D. Datta, E. Flynn, L. Zeng, H. T. Cohen, D. M. Briscoe, and S. Pal
Overexpression of Vascular Endothelial Growth Factor and the Development of Post-Transplantation Cancer
Cancer Res., July 15, 2008; 68(14): 5689 - 5698.
[Abstract] [Full Text] [PDF]

Home page
 ThoraxHome page
R Zhai, M N Gong, W Zhou, T B Thompson, P Kraft, L Su, and D C Christiani
Genotypes and haplotypes of the VEGF gene are associated with higher mortality and lower VEGF plasma levels in patients with ARDS
Thorax, August 1, 2007; 62(8): 718 - 722.
[Abstract] [Full Text] [PDF]

Home page
 Clin. Cancer Res.Home page
L. A. Hefler, A. Mustea, D. Konsgen, N. Concin, B. Tanner, R. Strick, G. Heinze, C. Grimm, E. Schuster, C. Tempfer, et al.
Vascular Endothelial Growth Factor Gene Polymorphisms Are Associated with Prognosis in Ovarian Cancer
Clin. Cancer Res., February 1, 2007; 13(3): 898 - 901.
[Abstract] [Full Text] [PDF]

Home page
 Cancer Epidemiol. Biomarkers Prev.Home page
N. Kataoka, Q. Cai, W. Wen, X.-O. Shu, F. Jin, Y.-T. Gao, and W. Zheng
Population-Based Case-Control Study of VEGF Gene Polymorphisms and Breast Cancer Risk among Chinese Women.
Cancer Epidemiol. Biomarkers Prev., June 1, 2006; 15(6): 1148 - 1152.
[Abstract] [Full Text] [PDF]

Home page
 Am. J. Physiol. Heart Circ. Physiol.Home page
S. J. Prior, J. M. Hagberg, C. M. Paton, L. W. Douglass, M. D. Brown, J. C. McLenithan, and S. M. Roth
DNA sequence variation in the promoter region of the VEGF gene impacts VEGF gene expression and maximal oxygen consumption
Am J Physiol Heart Circ Physiol, May 1, 2006; 290(5): H1848 - H1855.
[Abstract] [Full Text] [PDF]

Home page
 Mol Hum ReprodHome page
I. Banyasz, S. Szabo, G. Bokodi, A. Vannay, B. Vasarhelyi, A. Szabo, T. Tulassay, and J. Rigo Jr
Genetic polymorphisms of vascular endothelial growth factor in severe pre-eclampsia
Mol. Hum. Reprod., April 1, 2006; 12(4): 233 - 236.
[Abstract] [Full Text] [PDF]

Home page
 J. Immunol.Home page
G. Boulday, Z. Haskova, M. E. J. Reinders, S. Pal, and D. M. Briscoe
Vascular Endothelial Growth Factor-Induced Signaling Pathways in Endothelial Cells That Mediate Overexpression of the Chemokine IFN-{gamma}-Inducible Protein of 10 kDa In Vitro and In Vivo.
J. Immunol., March 1, 2006; 176(5): 3098 - 3107.
[Abstract] [Full Text] [PDF]

Home page
 J. Am. Soc. Nephrol.Home page
K. Doi, E. Noiri, A. Nakao, T. Fujita, S. Kobayashi, and K. Tokunaga
Functional Polymorphisms in the Vascular Endothelial Growth Factor Gene Are Associated with Development of End-Stage Renal Disease in Males
J. Am. Soc. Nephrol., March 1, 2006; 17(3): 823 - 830.
[Abstract] [Full Text] [PDF]

Home page
 Am. J. Physiol. Lung Cell. Mol. Physiol.Home page
N. F. Voelkel, R. W. Vandivier, and R. M. Tuder
Vascular endothelial growth factor in the lung
Am J Physiol Lung Cell Mol Physiol, February 1, 2006; 290(2): L209 - L221.
[Abstract] [Full Text] [PDF]

Home page
 Rheumatology (Oxford)Home page
J. S. Seo, S.-S. Lee, S. I. Kim, W. H. Ryu, K. H. Sa, S. U. Kim, S. W. Han, E. J. Nam, J. Y. Park, W. K. Lee, et al.
Influence of VEGF gene polymorphisms on the severity of ankylosing spondylitis
Rheumatology, October 1, 2005; 44(10): 1299 - 1302.
[Abstract] [Full Text] [PDF]

Home page
 J. Med. Genet.Home page
W M Howell, S Ali, M J Rose-Zerilli, and S Ye
VEGF polymorphisms and severity of atherosclerosis
J. Med. Genet., June 1, 2005; 42(6): 485 - 490.
[Abstract] [Full Text] [PDF]

Home page
 Clin. Cancer Res.Home page
Q. Jin, K. Hemminki, K. Enquist, P. Lenner, E. Grzybowska, R. Klaes, R. Henriksson, B. Chen, J. Pamula, W. Pekala, et al.
Vascular Endothelial Growth Factor Polymorphisms in Relation to Breast Cancer Development and Prognosis
Clin. Cancer Res., May 15, 2005; 11(10): 3647 - 3653.
[Abstract] [Full Text] [PDF]

Home page
 Cancer Epidemiol. Biomarkers Prev.Home page
S. J. Lee, S. Y. Lee, H.-S. Jeon, S. H. Park, J. S. Jang, G. Y. Lee, J. W. Son, C. H. Kim, W. K. Lee, S. Kam, et al.
Vascular Endothelial Growth Factor Gene Polymorphisms and Risk of Primary Lung Cancer
Cancer Epidemiol. Biomarkers Prev., March 1, 2005; 14(3): 571 - 575.
[Abstract] [Full Text] [PDF]

Home page
 Am. J. Physiol. Renal Physiol.Home page
P. H. Lapchak, M. Melter, S. Pal, J. A. Flaxenburg, C. Geehan, M. H. Frank, D. Mukhopadhyay, and D. M. Briscoe
CD40-induced transcriptional activation of vascular endothelial growth factor involves a 68-bp region of the promoter containing a CpG island
Am J Physiol Renal Physiol, September 1, 2004; 287(3): F512 - F520.
[Abstract] [Full Text] [PDF]

Home page
 Rheumatology (Oxford)Home page
S. W. Han, G. W. Kim, J. S. Seo, S. J. Kim, K. H. Sa, J. Y. Park, J. Lee, S. Y. Kim, J. J. Goronzy, C. M. Weyand, et al.
VEGF gene polymorphisms and susceptibility to rheumatoid arthritis
Rheumatology, September 1, 2004; 43(9): 1173 - 1177.
[Abstract] [Full Text] [PDF]

Home page
 J. Immunol.Home page
J. A. Flaxenburg, M. Melter, P. H. Lapchak, D. M. Briscoe, and S. Pal
The CD40-Induced Signaling Pathway in Endothelial Cells Resulting in the Overexpression of Vascular Endothelial Growth Factor Involves Ras and Phosphatidylinositol 3-Kinase
J. Immunol., June 15, 2004; 172(12): 7503 - 7509.
[Abstract] [Full Text] [PDF]

Home page
 Nephrol Dial TransplantHome page
G. Gillerot, H. Debaix, and O. Devuyst
Genotyping: a new application for the spent dialysate in peritoneal dialysis
Nephrol. Dial. Transplant., May 1, 2004; 19(5): 1298 - 1301.
[Abstract] [Full Text] [PDF]

Home page
 ChestHome page
K. Morohashi, T. Takada, K. Omori, E. Suzuki, and F. Gejyo
Vascular Endothelial Growth Factor Gene Polymorphisms in Japanese Patients With Sarcoidosis
Chest, May 1, 2003; 123(5): 1520 - 1526.
[Abstract] [Full Text] [PDF]

Home page
 Cancer Res.Home page
A. Stevens, J. Soden, P. E. Brenchley, S. Ralph, and D. W. Ray
Haplotype Analysis of the Polymorphic Human Vascular Endothelial Growth Factor Gene Promoter
Cancer Res., February 15, 2003; 63(4): 812 - 816.
[Abstract] [Full Text] [PDF]


HOME CURRENT ISSUE ARCHIVES JASN Express ONLINE SUBMISSION AUTHOR INFO
EDITORIAL BOARD SUBSCRIBE FEEDBACK ALERTS HELP

Copyright © 2009 by the American Society of Nephrology. Online ISSN: 1533-3450 Print ISSN: 1046-6673